---
figid: PMC9496810__cancers-14-04386-g007
figtitle: 'White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug
  Candidates for Personalized Cancer Therapy'
organisms:
- Adenoviridae
- Human endogenous retroviruses
- Avian endogenous virus ev-1
- Mus musculus
- Cricetulus griseus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Cricetulus griseus
- Danio rerio
pmcid: PMC9496810
filename: cancers-14-04386-g007.jpg
figlink: /pmc/articles/PMC9496810/figure/cancers-14-04386-f007/
number: F7
caption: Secondary assay for the primary SFRP1 mimetic hits analyzing activity as
  Wnt pathway antagonist. The Wnt-reporter cell line LEADING LIGHT® (Enzo Life Sciences,
  Farmingdale, NY, USA) expresses luciferase upon stimulation of the Wnt pathway after
  the addition of recombinant Wnt3a as a Wnt signaling ligand. Candidate SFRP1 mimetic
  hits might inhibit the Wnt signaling pathway at different levels, which should result
  in inhibition of the luciferase-induced luminescence.
papertitle: 'White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug
  Candidates for Personalized Cancer Therapy.'
reftext: Edgar Dahl, et al. Cancers (Basel). 2022 Sep;14(18):4386.
year: '2022'
doi: 10.3390/cancers14184386
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: tumor suppressor proteins | mimetics | personalized cancer therapy | class
  2 tumor suppressor genes | DNA methylation drivers | SFRP1 | ITIH5 | small molecules
automl_pathway: 0.9461702
figid_alias: PMC9496810__F7
figtype: Figure
redirect_from: /figures/PMC9496810__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9496810__cancers-14-04386-g007.html
  '@type': Dataset
  description: Secondary assay for the primary SFRP1 mimetic hits analyzing activity
    as Wnt pathway antagonist. The Wnt-reporter cell line LEADING LIGHT® (Enzo Life
    Sciences, Farmingdale, NY, USA) expresses luciferase upon stimulation of the Wnt
    pathway after the addition of recombinant Wnt3a as a Wnt signaling ligand. Candidate
    SFRP1 mimetic hits might inhibit the Wnt signaling pathway at different levels,
    which should result in inhibition of the luciferase-induced luminescence.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP6
  - LRP5
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CTNNB1
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3A
  - GSK3B
  - HNF4A
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - TNFRSF14
  - Lrp6
  - Lrp5
  - Axin1
  - Apc
  - Ctnnb1
  - Dvl1
  - Gsk3b
  - Crebbp
  - Pag1
  - Cytip
  - lrp6
  - lrp5
  - apc
  - ctnnb1
  - gsk3ba
  - gsk3ab
  - elk4
---
